Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Stomach emptying study reveals clues to weight loss success after sleeve surgery

NCT ID NCT06407193

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 18 women who had sleeve gastrectomy surgery 2-3 years earlier. Researchers compared stomach emptying rates between those who lost a lot of weight (over 35% of total weight) and those who lost little (under 25%). They used MRI and a special scan to measure how fast food leaves the stomach, aiming to understand why some people lose more weight than others after this surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

18 people

The number who actually took part.

Started

May 2022

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Women after sleeve gastrectomy with either good or poor weight loss

Ages

18 to 55 years

Sex

Female participants only

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women aged between 20 and 55 years who underwent sleeve gastrectomy as primary procedure with either TWL \< 25% or TWL \> 35%. * Patients who had a follow-up period of 2-3 years after sleeve gastrectomy Exclusion Criteria: * Maximum BMI \>50 kg/m2 * Patients with a disease known to affect appetite, gastric emptying or gastrointestinal motility * Patients who are unable to stop medications that affect gastric emptying and/or motility prior to measurements. It is depending on t1/2 for how long they need to stop medication * Patients who started menopause * Patients with gastrointestinal problems or, gastric or intestinal diseases * Patients with a drug or alcohol addiction * Patients who are unable to stop smoking for 24h * Patients who are pregnant or lactating * Patients who have an intolerance or allergy for one of the components of the test product * Patients who have a contra-indication to MRI scanning

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bariatric surgery are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Rijnstate Hospital

    Arnhem, Gelderland, 6815AD, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.